John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $32.57 ($661K) on 2014-11-12, disclosed to the SEC on 2014-11-14.
Scheduled sale ($661k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 10,601 | $345K | 52.3% |
| 2 | $33.57 | 9,399 | $316K | 47.7% |
| Total | $33.04 avg | 20,000 | $661K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |